Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Exscientia plc stock logo
EXAI
Exscientia
$4.84
$4.97
$3.80
$6.49
$632.93M0.83682,104 shsN/A
Microsoft Corporation stock logo
MSFT
Microsoft
$495.94
-0.3%
$449.47
$344.79
$499.30
$3.69T1.0321.63 million shs34.52 million shs
NVIDIA Corporation stock logo
NVDA
NVIDIA
$157.75
+1.8%
$130.96
$86.62
$158.71
$3.85T2.12269.20 million shs258.59 million shs
RadNet, Inc. stock logo
RDNT
RadNet
$57.12
-1.6%
$55.94
$45.00
$93.65
$4.29B1.43680,220 shs1.05 million shs
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
$5.03
-6.9%
$4.88
$3.79
$12.36
$2.04B0.8415.68 million shs46.48 million shs
Schrodinger, Inc. stock logo
SDGR
Schrodinger
$20.61
+0.6%
$23.19
$16.60
$28.47
$1.51B1.63908,350 shs1.68 million shs
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Exscientia plc stock logo
EXAI
Exscientia
0.00%0.00%0.00%0.00%-8.68%
Microsoft Corporation stock logo
MSFT
Microsoft
0.00%+3.88%+8.12%+30.92%+9.68%
NVIDIA Corporation stock logo
NVDA
NVIDIA
0.00%+9.68%+13.33%+43.84%+24.80%
RadNet, Inc. stock logo
RDNT
RadNet
0.00%+3.42%+3.50%+15.53%-1.72%
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
0.00%0.00%+13.03%-13.43%-42.58%
Schrodinger, Inc. stock logo
SDGR
Schrodinger
0.00%+0.73%-3.87%+3.26%+10.51%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Exscientia plc stock logo
EXAI
Exscientia
0.2294 of 5 stars
1.00.00.00.00.61.70.6
Microsoft Corporation stock logo
MSFT
Microsoft
4.6769 of 5 stars
2.45.03.32.92.82.51.3
NVIDIA Corporation stock logo
NVDA
NVIDIA
4.8738 of 5 stars
3.55.01.73.02.72.51.9
RadNet, Inc. stock logo
RDNT
RadNet
3.6441 of 5 stars
2.82.00.04.62.32.50.0
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
1.9062 of 5 stars
3.21.00.00.02.71.70.6
Schrodinger, Inc. stock logo
SDGR
Schrodinger
2.7494 of 5 stars
3.52.00.00.02.62.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Exscientia plc stock logo
EXAI
Exscientia
2.00
Hold$5.003.31% Upside
Microsoft Corporation stock logo
MSFT
Microsoft
2.88
Moderate Buy$521.145.08% Upside
NVIDIA Corporation stock logo
NVDA
NVIDIA
2.93
Moderate Buy$175.7811.43% Upside
RadNet, Inc. stock logo
RDNT
RadNet
3.50
Strong Buy$69.6021.85% Upside
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
2.33
Hold$7.0039.17% Upside
Schrodinger, Inc. stock logo
SDGR
Schrodinger
3.00
Buy$32.8059.15% Upside

Current Analyst Ratings Breakdown

Latest EXAI, MSFT, NVDA, RXRX, RDNT, and SDGR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/26/2025
Microsoft Corporation stock logo
MSFT
Microsoft
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$482.00 ➝ $530.00
6/25/2025
Microsoft Corporation stock logo
MSFT
Microsoft
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$515.00 ➝ $600.00
6/25/2025
Microsoft Corporation stock logo
MSFT
Microsoft
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$565.00 ➝ $585.00
6/25/2025
NVIDIA Corporation stock logo
NVDA
NVIDIA
Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$175.00 ➝ $250.00
6/17/2025
NVIDIA Corporation stock logo
NVDA
NVIDIA
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$170.00 ➝ $200.00
6/16/2025
NVIDIA Corporation stock logo
NVDA
NVIDIA
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$175.00
6/16/2025
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$8.00 ➝ $5.00
6/13/2025
Microsoft Corporation stock logo
MSFT
Microsoft
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$515.00 ➝ $565.00
6/13/2025
RadNet, Inc. stock logo
RDNT
RadNet
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy ➝ Buy$69.00
6/12/2025
RadNet, Inc. stock logo
RDNT
RadNet
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeBuy ➝ Strong-Buy
6/11/2025
Microsoft Corporation stock logo
MSFT
Microsoft
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$540.00 ➝ $605.00
(Data available from 6/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Exscientia plc stock logo
EXAI
Exscientia
$25.60M24.72N/AN/A$2.54 per share1.91
Microsoft Corporation stock logo
MSFT
Microsoft
$245.12B15.04$14.86 per share33.38$36.12 per share13.73
NVIDIA Corporation stock logo
NVDA
NVIDIA
$130.50B29.50$3.06 per share51.59$3.44 per share45.86
RadNet, Inc. stock logo
RDNT
RadNet
$1.83B2.34$3.48 per share16.40$15.31 per share3.73
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
$58.84M34.75N/AN/A$2.61 per share1.93
Schrodinger, Inc. stock logo
SDGR
Schrodinger
$207.54M7.29N/AN/A$5.78 per share3.57
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Exscientia plc stock logo
EXAI
Exscientia
-$181.56M-$1.51N/AN/AN/A-882.09%-49.10%-33.13%N/A
Microsoft Corporation stock logo
MSFT
Microsoft
$88.14B$12.9438.3333.742.5235.79%32.74%18.13%7/29/2025 (Estimated)
NVIDIA Corporation stock logo
NVDA
NVIDIA
$72.88B$3.1050.8939.641.4051.69%105.09%72.19%8/27/2025 (Estimated)
RadNet, Inc. stock logo
RDNT
RadNet
$2.79M-$0.43N/A107.77N/A-1.73%1.41%0.48%8/6/2025 (Estimated)
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
-$463.66M-$1.77N/AN/AN/A-961.32%-74.70%-54.02%8/6/2025 (Estimated)
Schrodinger, Inc. stock logo
SDGR
Schrodinger
-$187.12M-$2.63N/AN/AN/A-83.39%-44.74%-26.29%7/30/2025 (Estimated)

Latest EXAI, MSFT, NVDA, RXRX, RDNT, and SDGR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/28/2025Q1 2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
$0.87$0.81-$0.06$0.76$43.09 billion$44.06 billion
5/7/2025Q1 2025
Schrodinger, Inc. stock logo
SDGR
Schrodinger
-$0.81-$0.82-$0.01-$0.82$54.60 million$59.55 million
5/5/2025Q1 2025
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
-$0.44-$0.50-$0.06-$0.50$18.12 million$14.75 million
4/30/2025Q3 2025
Microsoft Corporation stock logo
MSFT
Microsoft
$3.22$3.46+$0.24$3.46$68.54 billion$70.07 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Exscientia plc stock logo
EXAI
Exscientia
N/AN/AN/AN/AN/A
Microsoft Corporation stock logo
MSFT
Microsoft
$3.320.67%N/A25.66%23 Years
NVIDIA Corporation stock logo
NVDA
NVIDIA
$0.040.03%N/A1.29%1 Years
RadNet, Inc. stock logo
RDNT
RadNet
N/AN/AN/AN/AN/A
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
N/AN/AN/AN/AN/A
Schrodinger, Inc. stock logo
SDGR
Schrodinger
N/AN/AN/AN/AN/A

Latest EXAI, MSFT, NVDA, RXRX, RDNT, and SDGR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/10/2025
Microsoft Corporation stock logo
MSFT
Microsoft
quarterly$0.830.71%8/21/20258/21/20259/11/2025
5/28/2025
NVIDIA Corporation stock logo
NVDA
NVIDIA
quarterly$0.010.03%6/11/20256/11/20257/3/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Exscientia plc stock logo
EXAI
Exscientia
0.06
4.54
4.54
Microsoft Corporation stock logo
MSFT
Microsoft
0.12
1.37
1.36
NVIDIA Corporation stock logo
NVDA
NVIDIA
0.10
3.39
2.96
RadNet, Inc. stock logo
RDNT
RadNet
0.87
2.01
2.01
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
0.02
4.11
4.11
Schrodinger, Inc. stock logo
SDGR
Schrodinger
N/A
3.45
3.45

Institutional Ownership

CompanyInstitutional Ownership
Exscientia plc stock logo
EXAI
Exscientia
41.58%
Microsoft Corporation stock logo
MSFT
Microsoft
71.13%
NVIDIA Corporation stock logo
NVDA
NVIDIA
65.27%
RadNet, Inc. stock logo
RDNT
RadNet
77.90%
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
89.06%
Schrodinger, Inc. stock logo
SDGR
Schrodinger
79.05%

Insider Ownership

CompanyInsider Ownership
Exscientia plc stock logo
EXAI
Exscientia
16.40%
Microsoft Corporation stock logo
MSFT
Microsoft
0.03%
NVIDIA Corporation stock logo
NVDA
NVIDIA
4.17%
RadNet, Inc. stock logo
RDNT
RadNet
5.60%
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
8.43%
Schrodinger, Inc. stock logo
SDGR
Schrodinger
8.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Exscientia plc stock logo
EXAI
Exscientia
280130.77 million109.32 millionOptionable
Microsoft Corporation stock logo
MSFT
Microsoft
228,0007.43 billion7.43 billionOptionable
NVIDIA Corporation stock logo
NVDA
NVIDIA
36,00024.40 billion23.38 billionOptionable
RadNet, Inc. stock logo
RDNT
RadNet
11,02175.03 million70.83 millionOptionable
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
400406.49 million372.23 millionOptionable
Schrodinger, Inc. stock logo
SDGR
Schrodinger
79073.38 million67.07 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Exscientia stock logo

Exscientia NASDAQ:EXAI

Exscientia plc, an artificial intelligence (AI) driven Pharma-tech company, engages in design and develop differentiated medicines for diseases with high unmet patient needs. The company's lead product candidate GTAEXS617, a CDK7 inhibitor, which is currently in a Phase 1/2 trial to manage the potential toxicities associated with CDK7 as well as optimizing pharmacokinetics for maximizing on-target efficacy. It is also involved in the development of EXS4318, a PKC-theta inhibitor, under Phase 1 clinical trial for inflammation and immunology indications; EXS74539, a LSD1 inhibitor, under preclinical studies for SCLC, AML, and potential additional indications; EXS73565, a MALT1 inhibitor, under preclinical studies for multiple hematology indications; and DSP-0038, currently in Phase 1 studies. The company has collaboration agreements with Merck KGaA, Bristol Myers Squibb, Sanofi, Bill & Melinda Gates Foundation, Charité Universitätsmedizin Berlin, Rallybio, and GT Apeiron Therapeutics. Exscientia plc was founded in 2012 and is headquartered in Oxford, the United Kingdom.

Microsoft stock logo

Microsoft NASDAQ:MSFT

$495.94 -1.51 (-0.30%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$495.76 -0.19 (-0.04%)
As of 06/27/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Microsoft Corporation develops and supports software, services, devices and solutions worldwide. The Productivity and Business Processes segment offers office, exchange, SharePoint, Microsoft Teams, office 365 Security and Compliance, Microsoft viva, and Microsoft 365 copilot; and office consumer services, such as Microsoft 365 consumer subscriptions, Office licensed on-premises, and other office services. This segment also provides LinkedIn; and dynamics business solutions, including Dynamics 365, a set of intelligent, cloud-based applications across ERP, CRM, power apps, and power automate; and on-premises ERP and CRM applications. The Intelligent Cloud segment offers server products and cloud services, such as azure and other cloud services; SQL and windows server, visual studio, system center, and related client access licenses, as well as nuance and GitHub; and enterprise services including enterprise support services, industry solutions, and nuance professional services. The More Personal Computing segment offers Windows, including windows OEM licensing and other non-volume licensing of the Windows operating system; Windows commercial comprising volume licensing of the Windows operating system, windows cloud services, and other Windows commercial offerings; patent licensing; and windows Internet of Things; and devices, such as surface, HoloLens, and PC accessories. Additionally, this segment provides gaming, which includes Xbox hardware and content, and first- and third-party content; Xbox game pass and other subscriptions, cloud gaming, advertising, third-party disc royalties, and other cloud services; and search and news advertising, which includes Bing, Microsoft News and Edge, and third-party affiliates. The company sells its products through OEMs, distributors, and resellers; and directly through digital marketplaces, online, and retail stores. The company was founded in 1975 and is headquartered in Redmond, Washington.

NVIDIA stock logo

NVIDIA NASDAQ:NVDA

$157.75 +2.73 (+1.76%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$157.59 -0.16 (-0.10%)
As of 06/27/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NVIDIA Corporation provides graphics and compute and networking solutions in the United States, Taiwan, China, Hong Kong, and internationally. The Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU or vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building and operating metaverse and 3D internet applications. The Compute & Networking segment comprises Data Center computing platforms and end-to-end networking platforms, including Quantum for InfiniBand and Spectrum for Ethernet; NVIDIA DRIVE automated-driving platform and automotive development agreements; Jetson robotics and other embedded platforms; NVIDIA AI Enterprise and other software; and DGX Cloud software and services. The company's products are used in gaming, professional visualization, data center, and automotive markets. It sells its products to original equipment manufacturers, original device manufacturers, system integrators and distributors, independent software vendors, cloud service providers, consumer internet companies, add-in board manufacturers, distributors, automotive manufacturers and tier-1 automotive suppliers, and other ecosystem participants. NVIDIA Corporation was incorporated in 1993 and is headquartered in Santa Clara, California.

RadNet stock logo

RadNet NASDAQ:RDNT

$57.12 -0.93 (-1.60%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$58.02 +0.91 (+1.58%)
As of 06/27/2025 06:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

Recursion Pharmaceuticals stock logo

Recursion Pharmaceuticals NASDAQ:RXRX

$5.03 -0.37 (-6.85%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$5.05 +0.02 (+0.40%)
As of 06/27/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Schrodinger stock logo

Schrodinger NASDAQ:SDGR

$20.61 +0.12 (+0.59%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$20.64 +0.03 (+0.15%)
As of 06/27/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.